While these small number of studies support a tumor-promoting role of Nox4 derived from activated fibroblasts, direct evidence linking this pro-oxidant to the tumor-supporting CAF phenotype and the mechanisms involved is lacking, particularly in breast cancer. This evidence concerns the gene NOX4 and neoplasm.